squalamine has been researched along with Branch Vein Occlusion in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, AY; Wroblewski, JJ | 1 |
Blake, DA; Farahat, HG; Genaidy, M; Holroyd, KJ; Kazi, AA; Passos-Machado, E; Peyman, GA; Williams, JI | 1 |
1 trial(s) available for squalamine and Branch Vein Occlusion
Article | Year |
---|---|
Topical Squalamine 0.2% and Intravitreal Ranibizumab 0.5 mg as Combination Therapy for Macular Edema Due to Branch and Central Retinal Vein Occlusion: An Open-Label, Randomized Study.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Cholestanols; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2016 |
1 other study(ies) available for squalamine and Branch Vein Occlusion
Article | Year |
---|---|
Effect of squalamine on iris neovascularization in monkeys.
Topics: Angiogenesis Inhibitors; Animals; Cholestanols; Disease Models, Animal; Fluorescein Angiography; Infusions, Intravenous; Injections; Iris; Laser Coagulation; Macaca fascicularis; Neovascularization, Pathologic; Retinal Vein; Retinal Vein Occlusion; Vitreous Body | 2002 |